These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 22506276)

  • 1. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage.
    Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B
    Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double targeting of tumours with pyrenyl-modified dendrimers encapsulated in an arene-ruthenium metallaprism.
    Pitto-Barry A; Barry NP; Zava O; Deschenaux R; Dyson PJ; Therrien B
    Chemistry; 2011 Feb; 17(6):1966-71. PubMed ID: 21274948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of cytotoxicity by combining pyrenyl-dendrimers and arene ruthenium metallacages.
    Pitto-Barry A; Zava O; Dyson PJ; Deschenaux R; Therrien B
    Inorg Chem; 2012 Jul; 51(13):7119-24. PubMed ID: 22716166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of floxuridine derivatives to cancer cells by water-soluble organometallic cages.
    Yi JW; Barry NP; Furrer MA; Zava O; Dyson PJ; Therrien B; Kim BH
    Bioconjug Chem; 2012 Mar; 23(3):461-71. PubMed ID: 22263930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery of lipophilic pyrenyl derivatives by encapsulation in a water soluble metalla-cage.
    Mattsson J; Zava O; Renfrew AK; Sei Y; Yamaguchi K; Dyson PJ; Therrien B
    Dalton Trans; 2010 Sep; 39(35):8248-55. PubMed ID: 20689885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation of pyrene-functionalized poly(benzyl ether) dendrons into a water-soluble organometallic cage.
    Pitto-Barry A; Barry NP; Zava O; Deschenaux R; Therrien B
    Chem Asian J; 2011 Jun; 6(6):1595-603. PubMed ID: 21626704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent correlation between drug release and portal size in metalla-cage drug-delivery systems.
    Barry NP; Zava O; Dyson PJ; Therrien B
    Chemistry; 2011 Aug; 17(35):9669-77. PubMed ID: 21735491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterisation and in vitro anticancer activity of hexanuclear thiolato-bridged arene ruthenium metalla-prisms.
    Furrer MA; Garci A; Denoyelle-Di-Muro E; Trouillas P; Giannini F; Furrer J; Clavel CM; Dyson PJ; Süss-Fink G; Therrien B
    Chemistry; 2013 Feb; 19(9):3198-203. PubMed ID: 23344898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activity of opened arene ruthenium metalla-assemblies.
    Barry NP; Zava O; Furrer J; Dyson PJ; Therrien B
    Dalton Trans; 2010 Jun; 39(22):5272-7. PubMed ID: 20442944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
    Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ
    J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, spectroscopic characterization, photochemical and photophysical properties and biological activities of ruthenium complexes with mono- and bi-dentate histamine ligand.
    Cardoso CR; de Aguiar I; Camilo MR; Lima MV; Ito AS; Baptista MS; Pavani C; Venâncio T; Carlos RM
    Dalton Trans; 2012 Jun; 41(22):6726-34. PubMed ID: 22539182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of tetracationic arene ruthenium metalla-cycles.
    Barry NP; Edafe F; Therrien B
    Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA structural distortions induced by ruthenium-arene anticancer compounds.
    Gossens C; Tavernelli I; Rothlisberger U
    J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium(II) arene PTA (RAPTA) complexes: impact of enantiomerically pure chiral ligands.
    Kilpin KJ; Cammack SM; Clavel CM; Dyson PJ
    Dalton Trans; 2013 Feb; 42(6):2008-14. PubMed ID: 23187957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.
    Ang WH; Daldini E; Scolaro C; Scopelliti R; Juillerat-Jeannerat L; Dyson PJ
    Inorg Chem; 2006 Oct; 45(22):9006-13. PubMed ID: 17054361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.